[
  {
    "ts": null,
    "headline": "Are Options Traders Betting on a Big Move in Bristol-Myers Squibb Stock?",
    "summary": "Investors need to pay close attention to BMY stock based on the movements in the options market lately.",
    "url": "https://finnhub.io/api/news?id=882e19185cbe985228c14ec88387bf36d09095650abd0592d2568cac24e4333e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751310480,
      "headline": "Are Options Traders Betting on a Big Move in Bristol-Myers Squibb Stock?",
      "id": 135677418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Investors need to pay close attention to BMY stock based on the movements in the options market lately.",
      "url": "https://finnhub.io/api/news?id=882e19185cbe985228c14ec88387bf36d09095650abd0592d2568cac24e4333e"
    }
  },
  {
    "ts": null,
    "headline": "BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?",
    "summary": "BMY loses 16.3% YTD as pipeline setbacks and generic pressure offset gains from new drug approvals and sales.",
    "url": "https://finnhub.io/api/news?id=79b74f0e5deb8dc401148c4cc8edc93524acba19f258b859f4d95983298f5c3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751291400,
      "headline": "BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?",
      "id": 135657097,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY loses 16.3% YTD as pipeline setbacks and generic pressure offset gains from new drug approvals and sales.",
      "url": "https://finnhub.io/api/news?id=79b74f0e5deb8dc401148c4cc8edc93524acba19f258b859f4d95983298f5c3d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 3000 Growth Index",
    "summary": "Bristol-Myers Squibb Company added to Russell 3000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=995d2b5cb39ec0d43e51bc38687d84401b38a98433e17cb8e07a465da94a7260",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751291012,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 3000 Growth Index",
      "id": 135664595,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company added to Russell 3000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=995d2b5cb39ec0d43e51bc38687d84401b38a98433e17cb8e07a465da94a7260"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”",
    "summary": "Incyte Corporation (NASDAQ:INCY) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer appreciated the new CEO of the company, as he commented: “We then have Incyte. That’s a biotech company. It just got a new CEO, Bill Meury. He’s an industry veteran, known as a deal maker. […]",
    "url": "https://finnhub.io/api/news?id=5402a245ad1dbfcd6d393739c0a2ba61b2f32923c146a95fd4200fe0545dc34e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751289323,
      "headline": "Jim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”",
      "id": 135666207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Incyte Corporation (NASDAQ:INCY) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer appreciated the new CEO of the company, as he commented: “We then have Incyte. That’s a biotech company. It just got a new CEO, Bill Meury. He’s an industry veteran, known as a deal maker. […]",
      "url": "https://finnhub.io/api/news?id=5402a245ad1dbfcd6d393739c0a2ba61b2f32923c146a95fd4200fe0545dc34e"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to buy Capstan for up to $2.1 billion in immunology push",
    "summary": "(Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases.  The U.S. drugmaker has spent over $20 billion on acquisitions since 2023 as its flagship rheumatoid arthritis drug, Humira, lost patent protection.  Capstan develops CAR-T therapies, which use a patient's own immune cells, specifically T-cells, to fight diseases.",
    "url": "https://finnhub.io/api/news?id=1ae7614f475c00531f3dbe2acbf715de5078e4f06d6d3394596db612a35b334f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751287323,
      "headline": "AbbVie to buy Capstan for up to $2.1 billion in immunology push",
      "id": 135666209,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "(Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases.  The U.S. drugmaker has spent over $20 billion on acquisitions since 2023 as its flagship rheumatoid arthritis drug, Humira, lost patent protection.  Capstan develops CAR-T therapies, which use a patient's own immune cells, specifically T-cells, to fight diseases.",
      "url": "https://finnhub.io/api/news?id=1ae7614f475c00531f3dbe2acbf715de5078e4f06d6d3394596db612a35b334f"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 1000 Growth Index",
    "summary": "Bristol-Myers Squibb Company added to Russell 1000 Growth Index...",
    "url": "https://finnhub.io/api/news?id=6bc3d6ad705dd4dea4f1f9dde50c4148527edf76a1391c5f94ba68ee25188bb1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751274412,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 1000 Growth Index",
      "id": 135651842,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company added to Russell 1000 Growth Index...",
      "url": "https://finnhub.io/api/news?id=6bc3d6ad705dd4dea4f1f9dde50c4148527edf76a1391c5f94ba68ee25188bb1"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 3000E Growth Index",
    "summary": "Bristol-Myers Squibb Company added to Russell 3000E Growth Index...",
    "url": "https://finnhub.io/api/news?id=700b0a536cdfd0532d7d7e8e8565152c77b07a95ce3ac099bfe7d0757b7363a4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751255632,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell 3000E Growth Index",
      "id": 135643696,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company added to Russell 3000E Growth Index...",
      "url": "https://finnhub.io/api/news?id=700b0a536cdfd0532d7d7e8e8565152c77b07a95ce3ac099bfe7d0757b7363a4"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell Top 200 Growth Index",
    "summary": "Bristol-Myers Squibb Company added to Russell Top 200 Growth Index...",
    "url": "https://finnhub.io/api/news?id=2e8e95c3f91150c0e4d584c6c51bde239197e2a692df04fc2006accff1439b72",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751254863,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) added to Russell Top 200 Growth Index",
      "id": 135643200,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company added to Russell Top 200 Growth Index...",
      "url": "https://finnhub.io/api/news?id=2e8e95c3f91150c0e4d584c6c51bde239197e2a692df04fc2006accff1439b72"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company(NYSE: BMY) dropped from Russell 1000 Value-Defensive Index",
    "summary": "Bristol-Myers Squibb Company dropped from Russell 1000 Value-Defensive Index...",
    "url": "https://finnhub.io/api/news?id=eac636de829454d3b26f6fbcca5271149507194def5e22aeebdf3e93d5854ffc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751251424,
      "headline": "Bristol-Myers Squibb Company(NYSE: BMY) dropped from Russell 1000 Value-Defensive Index",
      "id": 135640353,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol-Myers Squibb Company dropped from Russell 1000 Value-Defensive Index...",
      "url": "https://finnhub.io/api/news?id=eac636de829454d3b26f6fbcca5271149507194def5e22aeebdf3e93d5854ffc"
    }
  }
]